Chemistry - A European Journal · 2015 · 43 citations · 26 references
Life SciencesBiotechnologyMicrobiologyMedical MicrobiologyMicrobial PathogenesisSynthetic BiologyAntibacterial AgentsAntibacterial TherapyAntimicrobial PeptidesCell-penetrating PeptidesMicrobial Synthetic BiologyAntibacterial PeptidesAntimicrobial Peptide ActivityEscherichia Coli
Naturally occurring antimicrobial peptides (AMPs) are powerful defence tools to tackle pathogenic microbes. However, limited natural production and high synthetic costs in addition to poor selectivity limit large-scale use of AMPs in clinical settings. Here, we present a series of synthetic AMPs (SAMPs) that exhibit highly selective and potent killing of Mycobacterium (minimum inhibitory concentration <20 μg mL(-1)) over E. coli or mammalian cells. These SAMPs are active against rapidly multiplying as well as growth saturated Mycobacterium cultures. These SAMPs are not membrane-lytic in nature, and are readily internalized by Mycobacterium and mammalian cells; whereas in E. coli, the lipopolysaccharide layer inhibits their cellular uptake, and hence, their antibacterial action. Upon internalization, these SAMPs interact with the unprotected genomic DNA of mycobacteria, and impede DNA-dependent processes, leading to bacterial cell death.
26
Worldwide Emergence of Extensively Drug-resistant Tuberculosis
Neha Shah, A Wright, Gill‐Han Bai et al. · Emerging infectious diseases · 2007 · 585 citations · Full text
Public Health, Infectious Disease Control, Antimicrobial Resistance +16
Varun Sambhy, Blake R. Peterson, Ayusman Sen · Angewandte Chemie International Edition · 2008 · 270 citations